Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival
β Scribed by A. Beeghly; D. Katsaros; H. Chen; S. Fracchioli; Y. Zhang; M. Massobrio; H. Risch; B. Jones; H. Yu
- Book ID
- 113960228
- Publisher
- Elsevier Science
- Year
- 2006
- Tongue
- English
- Weight
- 246 KB
- Volume
- 100
- Category
- Article
- ISSN
- 0090-8258
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background. The purpose of this study was to evaluate the prognostic ability of polymorphisms of three genes involved in the metabolism of tobacco carcinogens (GSTT1, GSTM1, GSTP1) and one polymorphism of a DNA repair gene (XRCC1) for patients diagnosed with squamous cell carcinoma (SCC). Methods.
## Abstract ## BACKGROUND. Pancreatic cancer is a multifactorial disease with metastasisβprone and therapyβresistant nature. The authors hypothesized that genetic variants of glutathione Sβtransferase (GST) affect detoxification of carcinogens and anticancer agents in the human pancreas and, thus,
## Abstract Glutathione __S__βtransferase (GST) enzymes detoxify chemotherapeutic drugs, and several studies have reported differences in survival for cancer patients who have variant genotypes for GSTP1, GSTM1 or GSTT1 enzymes. A recently described polymorphism alters hepatic expression of GSTA1,